It is currently Mon Dec 05, 2016 10:42 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Another day, another protein

Autoimmune Disease Cure may lie in Protein

Researchers at VIB, the Flanders Institute for Biotechnology, in connection with Ghent University and Katholieke Universiteit Leuven in Belgium, discovered a protein responsible for initiating this inflammation reaction. The protein, named MALT1, slices another protein called A20. In normal circumstances, A20 inhibits inflammation but when MALT1 is present, the inflammation reaction amplifies.

Scientists believe their findings will lead to the development of new medicines that counteract MALT1 ...
Read more : Another day, another protein | Views : 1560 | Replies : 0 | Forum : General Discussion



I've been holding back on this - the Lamotrigine trial is being extended by a few months. You are such a delicate soul that I didn't want to upset you. I still have high hopes for this trial, but the results will be a little longer in coming.

To cheer you up - I'm sure that they'll be some good news (research / drugs trials) soon.

What ...
Read more : Lamotrigine | Views : 1868 | Replies : 2 | Forum : Drug Pipeline

TNF-alpha and INF-gamme increases after Tysabri treatment

After 6 month open lable trial with Tysabri, patients expressed higher levels of TNF-alpha and INF-gamma in peripheral blood.



MBP 8298

The following article includes some possible dates when MBP 8298 will be launched.

Eli Lilly has been cleared to license BioMS Medical's multiple sclerosis drug MBP8298.

The US Federal Trade Commission has cleared the global licensing and development agreement that grants Eli Lilly exclusive worldwide rights to BioMS Medical's lead multiple sclerosis compound, MBP8298. This represents a major step forward for Lilly, as the company looks to diversify its traditionally psychiatry-focused CNS offerings by expanding ...
Read more : MBP 8298 | Views : 2132 | Replies : 4 | Forum : Drug Pipeline

Contribution of relapses to disability

A big question in MS is the connection (if any) between relapses and disability (long term). Trials involving drugs which are very effective at stopping / reducing relapses (Campath, Mitoxantrone etc) should provide answers as to whether substantially reducing relapses has long term benefits (such as substantially slowing down disability / stopping the progression of disability). The following research examines the relationship of relapses and disability.

Ian ... _disa.html ...
Read more : Contribution of relapses to disability | Views : 1298 | Replies : 0 | Forum : General Discussion

WalkAide on Good Morning America

Check out the following link for a story about a fellow MSer and her experience with the WalkAide ... 183&page=1

I continue to have a very positive experience with my WalkAide - glad that I spent the money. Hopefully, the insurance companies will decide to start some type of coverage for the device.

For those who are interested, you can go to a Hanger Prosthetic Clinic and try ...
Read more : WalkAide on Good Morning America | Views : 6479 | Replies : 8 | Forum : Medical Devices


Read more : 123 | Views : 1862 | Replies : 1 | Forum : Revimmune (cyclophosphamide or cytoxan)

Hidden Clothes

Read more : Hidden Clothes | Views : 1786 | Replies : 0 | Forum : Humor

4-AP (Fampridine-SR) passes FDA heart test

<shortened url>

Acorda Therapeutics (nasdaq: ACOR - news - people ) said its multiple sclerosis drug Fampridine-SR does not raise the risk of heart-related side effects anymore than a placebo in a so-called QT cardiac safety study required by the U.S. Food and Drug Administration. Acorda shares were up 20.1%, or $4.38, at $26.16, in afternoon trading.
Read more : 4-AP (Fampridine-SR) passes FDA heart test | Views : 1620 | Replies : 0 | Forum : Drug Pipeline

Newly Diagnosed and Untreated? We'd like you to give blood.

Accelerated Cure Project for MS is seeking out individuals who meet
the following criteria in order to fulfill a sample and data request
from researchers at NASA.

The researchers at NASA will be using repository samples to perform
pathogen and gene expression analyses in an effort to provide insight
into one of the potential causes of MS.

There are no drugs involved, only a blood draw and extensive


* Diagnosed MS within the ...
Read more : Newly Diagnosed and Untreated? We'd like you to give blood. | Views : 3902 | Replies : 17 | Forum : General Discussion


Login  •  Register


Total posts 235116 • Total topics 25366 • Total members 16578

Contact us | Terms of Service